Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |